Do Gut Hormones Contribute to Weight Loss and Glycaemic Outcomes after Bariatric Surgery?
Open accessThe DOI matches its Crossref record; 182 of the 183 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Bariatric surgery is an effective intervention for management of obesity through treating dysregulated appetite and achieving long-term weight loss maintenance. Moreover, significant changes in glucose homeostasis are observed after bariatric surgery including, in some cases, type 2 diabetes remission from the early postoperative period and postprandial hypoglycaemia. Levels of a number of gut hormones are dramatically increased from the early period after Roux-en-Y gastric bypass and sleeve gastrectomy—the two most commonly performed bariatric procedures—and they have been suggested as important mediators of the observed changes in eating behaviour and glucose homeostasis postoperatively. In this review, we summarise the current evidence from human studies on the alterations of gut hormones after bariatric surgery and their impact on clinical outcomes postoperatively. Studies which assess the role of gut hormones after bariatric surgery on food intake, hunger, satiety and glucose homeostasis through octreotide use (a non-specific inhibitor of gut hormone secretion) as well as with exendin 9–39 (a specific glucagon-like peptide-1 receptor antagonist) are reviewed. The potential use of gut hormones as biomarkers of successful outcomes of bariatric surgery is also evaluated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“thus potentially enabling a larger effect of exogenously given GLP1-RA [34].”
From Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study (2023) · cites this paper as [34]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The notion for combining entero-pancreatic hormone-based therapies for obesity treatment is supported by the efficacy of bariatric surgery on WL, an intervention leading to increased postprandial levels of multiple entero-pancreatic hormones [31, 32].”
From What is the pipeline for future medications for obesity? (2025) · cites this paper as [32]
In the citing paper
“The rapid delivery of nutrients to the L-cells in the distal small intestine and colon after bariatric surgery leads to increased secretion of gut hormones, especially postprandial GLP-1 and peptide YY.”
In the citing paper
“Both hormones are known to reduce food intake by stimulating satiety and decreasing appetite, which most likely plays a central role for the weight loss effect of bariatric surgery [34].”
In the citing paper
“the study by Lautenbach includes “poor” responders to bariatric surgery, which have been shown to have lower endogenous GLP-1 levels”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Haslam, D. W., & James, W. P. T. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67483-1 · Cited by 3,757
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371
Plasma Ghrelin Levels after Diet-Induced Weight Loss or Gastric Bypass Surgery
Cummings, D. E., Weigle, D. S., Frayo, R. S., Breen, P. A., Ma, M. K., Dellinger, E. P., & Purnell, J. Q. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012908 · Cited by 2,241
The biology of incretin hormones
Drucker, D. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.004 · Cited by 2,210
Glucagon-like peptide-1 7–36: a physiological incretin in man
Kreymann, B., Ghatei, M. A., Williams, G., & Bloom, S. R. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91194-9 · Cited by 1,928
Glucagon-like peptide 1 (GLP-1)
Müller, T. D., Finan, B., Bloom, S. R., D'Alessio, D., Drucker, D. J., Flatt, P. R., Fritsche, A., Gribble, F., Grill, H. J., Habener, J. F., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.010 · Cited by 1,868
Bray, G. A., Kim, K. K., Wilding, J. P. H., & on behalf of the World Obesity Federation (2017) · Obesity Reviews · doi:10.1111/obr.12551 · Cited by 1,612
Inhibition of Food Intake in Obese Subjects by Peptide YY 3–36
Batterham, R. L., Cohen, M. A., Ellis, S. M., Le Roux, C. W., Withers, D. J., Frost, G. S., Ghatei, M. A., & Bloom, S. R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030204 · Cited by 1,604
Long-term persistence of hormonal adaptations to weight loss
Sumithran, P., Prendergast, L. A., Delbridge, E., Purcell, K., Shulkes, A., Kriketos, A., & Proietto, J. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105816 · Cited by 1,449 · cited 3×
“On a low-calorie diet, people usually report an increase in hunger, a decrease in satiety and an increased desire to eat [18,27,28] and this is likely due to robust compensatory processes that resist a drift of body fat stores below an established “set point” [29,30].”
BackgroundBray, G. A., Frühbeck, G., Ryan, D. H., & Wilding, J. P. H. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00271-3 · Cited by 1,036
Cited by
What is the pipeline for future medications for obesity?
Melson, E., Ashraf, U., Papamargaritis, D., & Davies, M. J. (2025) · International Journal of Obesity · doi:10.1038/s41366-024-01473-y · Cited by 332
“The notion for combining entero-pancreatic hormone-based therapies for obesity treatment is supported by the ef fi cacy of bariatric surgery on WL, an intervention leading to increased postprandial levels of multiple entero-pancreatic hormones [31, 32].”
Self-citationMok, J., Adeleke, M. O., Brown, A., Magee, C. G., Firman, C., Makahamadze, C., Jassil, F. C., Marvasti, P., Carnemolla, A., Devalia, K., et al. (2023) · JAMA Surgery · doi:10.1001/jamasurg.2023.2930 · Cited by 178
Jensen, A. B., Renström, F., Aczél, S., Folie, P., Biraima-Steinemann, M., Beuschlein, F., & Bilz, S. (2023) · Obesity Surgery · doi:10.1007/s11695-023-06484-8 · Cited by 161
Mechanisms of Weight Loss After Obesity Surgery
Akalestou, E., Miras, A. D., Rutter, G. A., & le Roux, C. W. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab022 · Cited by 136
Haddad, A. J., Suter, M., Greve, J. W. M., Shikora, S. A., Prager, G., Dayyeh, B. K. A., Neto, M. G., Grothe, K. B., Herrera, M. F., Kow, L., et al. (2024) · Obesity Surgery · doi:10.1007/s11695-024-07489-7 · Cited by 85
“Studies have demonstrated accelerated alcohol absorption, higher maximum alcohol concentration [57], and higher rates of alcohol use disorder [47, 48, 58–60] after MBS. Opioid consumption may increase as well for some patients [61].”
Tseng, C. (2021) · Biomolecules · doi:10.3390/biom11071022 · Cited by 60
Obesity Management in the Primary Prevention of Hepatocellular Carcinoma
Zunica, E. R. M., Heintz, E. C., Axelrod, C. L., & Kirwan, J. P. (2022) · Cancers · doi:10.3390/cancers14164051 · Cited by 32
Medical and Surgical Treatment of Obesity
Reid, T. J., & Körner, J. (2022) · Medical Clinics of North America · doi:10.1016/j.mcna.2022.03.002 · Cited by 40
Towards precision medicine in bariatric surgery prescription
Pereira, S. S., Guimarães, M., & Monteiro, M. P. (2023) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-023-09801-9 · Cited by 39
The role of GLP-1 signaling in hypoglycemia due to hyperinsulinism
Danowitz, M., & De Leon, D. D. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.863184 · Cited by 23
“Exendin-(9-39) is a truncated form of exendin4, a GLP-1 receptor agonist, isolated from the saliva of the gila monster.”
BackgroundInfluentialDischinger, U., Kötzner, L., Kovatcheva‐Datchary, P., Kleinschmidt, H., Haas, C., Perez, J., Presek, C., Koschker, A., Miras, A. D., Hankir, M. K., et al. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155341 · Cited by 22
“U. Dischinger et al. that this known hormonal mechanism of bariatric surgery, especially RYGB and sleeve gastrectomy [26 – 28], is intact in these patients.”
Appetite and Satiety Control—Contribution of Gut Mechanisms
Feinle‐Bisset, C., & Horowitz, M. (2021) · Nutrients · doi:10.3390/nu13103635 · Cited by 19
Significance of Hormone Alteration Following Bariatric Surgery
Slouha, E., Elkersh, E. M., Shay, A., Ghosh, S., Mahmood, A., & Gorantla, V. R. (2023) · Cureus · doi:10.7759/cureus.49053 · Cited by 23
Faucher, P., Carette, C., Jannot, A., Gatta‐Cherifi, B., Straaten, A. V., Piquet, M., Raverot, G., Alligier, M., Batisse, T., Ziegler, O., et al. (2022) · Obesity Surgery · doi:10.1007/s11695-022-06079-9 · Cited by 19
Holst, J. J., Madsbad, S., Bojsen-Møller, K. N., Dirksen, C., & Svane, M. S. (2024) · Peptides · doi:10.1016/j.peptides.2024.171199 · Cited by 18
“Numerous studies have addressed the role of the gut hormones for the improvements in glucose metabolism after gastric bypass [20, 45, 75 – 79].”
BackgroundPereira, M., Menezes, S., FRANCO, A. J., Marcolin, P., & Tomera, M. (2024) · Obesity Surgery · doi:10.1007/s11695-024-07486-w · Cited by 18
“This hypothesis aligns with our findings of enhanced weight loss when lira-glutide is used as an adjunct to bariatric surgery and highlights the potential for GLP-1 RAs to optimize outcomes in patients with persistent obesity after metabolic surgery [18].”
Gut peptides before and following Roux‐En‐Y gastric bypass: A systematic review and meta‐analysis
Simoneau, M., McKay, B., Brooks, E., Doucet, É., & Baillot, A. (2024) · Obesity Reviews · doi:10.1111/obr.13702 · Cited by 14
Diabetes Mellitus and Gastric Cancer: Correlation and Potential Mechanisms
Wang, L., & Zhang, Z. (2023) · Journal of Diabetes Research · doi:10.1155/2023/4388437 · Cited by 17
“In addition, ghrelin, another gut hormone that stimulates appetite and food intake, is mainly produced by gastric X/A cells, and its level is reduced after gastrectomy [43].”
BackgroundHengist, A., Sciarrillo, C. M., Guo, J., Walter, M. F., & Hall, K. D. (2024) · Obesity · doi:10.1002/oby.24104 · Cited by 13
Abdallah, H., Klink, W. H., Derienne, J., Voican, C. S., Perlemuter, G., Courie, R., Dagher, I., & Tranchart, H. (2025) · Obesity Surgery · doi:10.1007/s11695-025-08210-y · Cited by 18
“Nevertheless, it was demonstrated that inadequate weight loss after BS is often associated with increased appetite and an unfavorable postoperative gut hormone profile, including reduced circulating GLP-1 levels [25, 26].”
Mechanisms of Action of Bariatric Surgery on Body Weight Regulation
Alabduljabbar, K. A., Bonanos, E., Miras, A. D., & le Roux, C. W. (2023) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2023.08.002 · Cited by 16
Novel neural pathways targeted by GLP-1R agonists and bariatric surgery
Hankir, M. K., & Lutz, T. A. (2024) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-024-03047-3 · Cited by 16
“…and VSG enhance the release of endogenous GLP-1 from enteroendocrine cells due to accelerated nutrient passage through the gut along with enhanced luminal bile acid signaling [10–13], this gut hormone was originally widely thought to contribute to their effects on food intake and body weight [14].”
Lim, J. J., Liu, Y., Lu, L. W., Sequeira, I. R., & Poppitt, S. D. (2023) · Nutrients · doi:10.3390/nu15102399 · Cited by 11
“Furthermore, Papamargaritis and le Roux [59] recently showed that hunger suppression following RYGB was attenuated by GLP-1 and PYY receptor antagonists, supporting the hypothesis that GLP-1 and PYY are involved in suppressing hunger or promoting satiety after RYGB.”
BackgroundNedelcut, S., Axer, S. S., & Olbers, T. (2024) · Metabolism · doi:10.1016/j.metabol.2024.155799 · Cited by 9
Remission of type 2 diabetes: position statement of the Italian society of diabetes (SID)
Capoccia, D., Leonetti, F., Natali, A., Tricò, D., Perrini, S., Sbraccia, P., Guglielmi, V., & On behalf of the Italian Society of Diabetes (SID) (2024) · Acta Diabetologica · doi:10.1007/s00592-024-02317-x · Cited by 11
“Both hormones are known to reduce food intake by stimulating satiety and decreasing appetite, which likely plays a central role in the weight loss achieved with bariatric surgery [111].”
BackgroundWang, J., Zhao, J., Zhong, Y., He, C., & Hu, F. (2024) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000806 · Cited by 10
“Apart from the aforementioned promotion of insulin absorption by the liver through a low-energy diet (28), the reduced fat content and lighter burden on fat cells resulting from weight loss can decrease the inhibition of insulin in skeletal muscle (32).”
Ratner, C., Shin, J. H., Dwibedi, C. K., Tremaroli, V., Bjerregaard, A., Hartmann, B., Bäckhed, F., Leinninger, G. M., Seeley, R. J., & Holst, B. (2021) · Endocrinology · doi:10.1210/endocr/bqab130 · Cited by 6
Janot, C., Fourati, S., Bernard, A., Besnard, P., Gall, M. L., Ledoux, S., & Beyec, J. L. (2025) · Clinical Nutrition · doi:10.1016/j.clnu.2025.09.014 · Cited by 5
Lammert, M., Medawar, E., Hartmann, H., Grasser, L., Dietrich, A., Fenske, W. K., & Horstmann, A. (2023) · Physiology & Behavior · doi:10.1016/j.physbeh.2023.114279 · Cited by 8
Cano, R., Rodríguez, D. L., Durán, P., Cano, C., Rojas-Gómez, D. M., Rivera-Porras, D., Barboza-González, P., Fuentes-Barría, H., Angarita, L., Boscan, A., et al. (2025) · Nutrients · doi:10.3390/nu17193123 · Cited by 10
“GLP-1, however, acts via vagal afferents [56], stimulates insulin release [57,58], inhibits counter-regulatory hormones such as glucagon [59], and delays GE by stimulating nitrergic myenteric neurons, thereby reducing GI motility [60,61].”
Shang‐Guan, Z., Lin, G., Liu, Z.-Y., Zhong, Q., Huang, Q., Li, P., Xie, J., Wang, J.-B., Lü, J., Chen, Q., et al. (2024) · Obesity Surgery · doi:10.1007/s11695-024-07146-z · Cited by 7
“Leptin resistance due to chronically high leptin levels leads to a poor weight loss response [49, 50] because it interferes with leptin binding to the satiety center in the ventral medial nucleus of the hypothalamus, disrupting the inhibitory effect of leptin on the food-promoting hormone…”
Comprehensive visualization of bariatric surgery and gut microbiota research: a global analysis
Zyoud, S. H., Shakhshir, M. H., Barqawi, A., Abushanab, A. S., Koni, A. A., Khilfeh, S., Shahwan, M. J., Jairoun, A. A., Taha, A. A., Abushamma, F., et al. (2024) · Translational Medicine Communications · doi:10.1186/s41231-024-00173-z · Cited by 7
“These hormone levels increase shortly after bariatric procedures such as Roux-en-Y gastric bypass and sleeve gastrectomy, potentially serving as crucial regulators of postoperative changes in eating patterns and glucose balance [92].”
BackgroundÖzmen, F., Şahin, T. T., Dolgun, A., & Özmen, M. M. (2024) · International Journal of Surgery · doi:10.1097/js9.0000000000001608 · Cited by 7
“Although various hormones and adi-pokines are linked to obesity, ghrelin and resistin are two molecules being actively investigated for possible roles in the mechanism of obesity [1 – 4] .”
BackgroundGut Peptide Alterations in Type 2 Diabetes and Obesity: A Narrative Review
Tzeravini, E., Simati, S., Anastasiou, I. A., Dalamaga, Μ., & Kokkinos, A. D. (2026) · Current Obesity Reports · doi:10.1007/s13679-026-00687-7 · Cited by 8
“Each bariatric procedure is characterized by a distinct hormonal signature, with Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) inducing rapid and pronounced increases in postprandial gut hormone secretion [232, 250].”
Ingestive Behavior and Precision Nutrition: Part of the Puzzle
Biruete, A., Buobu, P. S., Considine, R. V., Hoxha, E. M., Eicher‐Miller, H. A., Kinzig, K. P., Panjwani, A. A., Running, C. A., Rutigliani, G., Savaiano, D. A., et al. (2025) · Advances in Nutrition · doi:10.1016/j.advnut.2025.100531 · Cited by 7
“In contrast, postprandial GLP-1 and PYY are significantly increased following bariatric procedures [338].”
Gut Factors Mediating the Physiological Impact of Bariatric Surgery
Bethea, M. M., & Sandoval, D. A. (2022) · Current Diabetes Reports · doi:10.1007/s11892-022-01478-9 · Cited by 7
Discordance between gut-derived appetite hormones and energy intake in humansPreprint
Hengist, A., Sciarrillo, C. M., Guo, J., Walter, M. F., & Hall, K. D. (2023) · medRxiv · doi:10.1101/2023.05.10.23289718 · Cited by 6
“Some forms of bariatric surgery result in substantial increases in postprandial GLP-1 and PYY 143 [38-40], likely due to altered gastric emptying and intestinal nutrient delivery.”
BackgroundHany, M., Demerdash, H. M., Abouelnasr, A. A., & Torensma, B. (2024) · Biomarker Insights · doi:10.1177/11772719241256496 · Cited by 4
Chang, T., Huang, I. Y.-W., Huang, C., & Chang, P. (2023) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2023.01.010 · Cited by 4
Puig, R., Rodríguez‐Peña, M., Hernández-Montoliu, L., Astiarraga, B., Martínez, E., Balibrea, J. M., Llauradó, G., Tarascó, J., Boza, A. C., Joaquín, C., et al. (2026) · International Journal of Obesity · doi:10.1038/s41366-025-01971-7 · Cited by 2
Hu, H., Tian, Q., Wang, L., 穆丽茜, Zhou, X., Liu, B., Guo, J., Hou, Y., & Wang, X. (2026) · Nutrition · doi:10.1016/j.nut.2026.113168 · Cited by 2
Lower ghrelin levels does not impact the metabolic benefit induced by Roux-en-Y gastric bypass
Liang, Y. J., Yu, R., He, R., Sun, L., Luo, C., Feng, L., Chen, H., Yin, Y., & Zhang, W. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.891379 · Cited by 2
Marcillo, W. E. P., Vásquez, H. A., & Jarrim, K. (2022) · RECIAMUC · doi:10.26820/reciamuc/6.(3).julio.2022.612-624 · Cited by 1
Obesity and Appetite: Evidence for a Neurobehavioral Model of Obesity Risk and Maintenance
Thapaliya, G., Sadler, J. R., Jansen, E., & Carnell, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819641-0.00142-0 · Cited by 3
Handley, D., Almansoori, S., Sato, M. S., Amin, H. A., Alsters, S., Chahal, H., Purkayastha, S., Murphy, K. G., van Haelst, M. M., le Roux, C. W., et al. (2023) · medRxiv · doi:10.1101/2023.05.22.23290347 · Cited by 1
“…and the importance of GLP1 in long-term outcomes of bariatric surgery are well characterised (Werling et al., 2014; Amouyal and Andreelli, 2016; Papamargaritis and le Roux, 2021), Thus, the efficacy of GLP1 agonists and bariatric surgery for the treatment of T2D and obesity may be dependent on…”
BackgroundFuture Perspectives in the Management of Obesity
Garcha, S. C., & Kalra, S. (2025) · Springer eBooks · doi:10.1007/978-981-96-1651-0_6 · Cited by 2
Ahmad, M., Alamgir, M., Ahmad, W., Khan, M., & Sahibzada, A. H. (2025) · Pakistan Journal of Health Sciences · doi:10.54393/pjhs.v6i6.3007 · Cited by 1
Martines, G., Tomasicchio, G., Rotelli, M. T., & Fazio, M. D. (2025) · Frontiers in Surgery · doi:10.3389/fsurg.2025.1624455 · Cited by 2
Campbell, C., peddi, P., Rogers, A. M., DuCoin, C. G., Sujka, J. A., & Docimo, S. (2025) · Obesity Surgery · doi:10.1007/s11695-025-08412-4 · Cited by 2
“Weight recurrence may arise from multiple factors, including pouch dilation, gastrogastric fistula formation, and socio-economic and psychosocial issues [38 , 39].”
Metabolic Profiling of Type 2 Diabetes Patients after Bariatric Surgery by Raman Spectroscopy
Bonizzi, A., Sevieri, M., Sitia, L., Rizzi, A., Conti, L., Corsi, F., Morasso, C., & Mazzucchelli, S. (2021) · Applied Sciences · doi:10.3390/app112210710 · Cited by 1
Metelcová, T., Hainer, V., Hill, M., Kalousková, P., Vrbíková, J., Šrámková, P., Fried, M., Braunerová, R. T., & Kunešová, M. (2023) · Physiological Research · doi:10.33549/physiolres.935179 · Cited by 2
Medicatie voor obesitas: vooruitgang en uitdagingen
Muskiet, M. H. A., & Boon, M. R. (2024) · Nederlands Tijdschrift voor Diabetologie · doi:10.1007/s12467-024-1569-4 · Cited by 1
Neto, A. A. D. M. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2022.tde-01032023-161502 · Cited by 1
Nakamura, Y., Horie, I., Kanetaka, K., Eguchi, S., Nakamichi, S., Hongo, R., Takashima, M., Kawakami, A., & Abiru, N. (2022) · Endocrine Journal · doi:10.1507/endocrj.ej22-0224
Abdel-Malek, M., Thayabaran, D., & Miras, A. D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91707-0.00010-3
Hany, M., & Torensma, B. (2024) · Journal of Bariatric Surgery · doi:10.4103/jbs.jbs_18_23
Lytvyak, E., Zarrinpar, A., Ore, C. L. D., Lee, E., Yazdani-Boset, K., Horgan, S., & Grunvald, E. L. (2024) · Obesity Pillars · doi:10.1016/j.obpill.2024.100111 · Cited by 1
Future basic research lines on malabsorptive procedures
Ibáñez, N. L., Leal-Zafra, A., & Ruíz-Tóvar, J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-21672-5.00006-8
Martínez, M. M. M., Pérez-Berrio, D. M., & S, V. (2024) · Revista Mvz Córdoba · doi:10.21897/rmvz.3483
“Bariatric surgery provides the most robust option for treating obesity compared to other currently available strategies that include lifestyle modification, pharmacotherapy, and endoscopic therapy (6,7,8,9).”
BackgroundMachine Learning for Improved Bariatric Surgery Management
D’Amore, A., D’Onofrio, G., Fidecicchi, A., Triassi, M., & Marino, M. R. (2024) · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany · doi:10.1007/978-3-031-80355-0_38
Islet effects of cholecystokinin and exploitation in diabetes
Tanday, N., Irwin, N., & Flatt, P. R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-23720-1.00003-4
The Importance of Nutrition Before and Following Metabolic/Bariatric Surgery
Bayar, E., & Besler, H. T. (2025) · Trends in Surgical Sciences · doi:10.61745/tss.1671486
The endocannabinoidome and its role in the central and peripheral control of food intake
Silvestri, C., & Marzo, V. D. (2025) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-443-13908-6.00013-x · Cited by 3
Yu, Q., Sun, J., Yang, Y., Zhu, W., & Ma, Y. (2026) · Obesity Surgery · doi:10.1007/s11695-026-08489-5
Hormonal Regulation of Food Intake
Breton, J., Langlois, L. D., Coëffier, M., & Achamrah, N. (2026) · Endocrinology · doi:10.1007/978-3-030-71067-5_2-1
Hormonal and Biochemical Changes After Sleeve Gastrectomy
Macias-Gamero, I. (2026) · Springer eBooks · doi:10.1007/978-3-032-25644-7_22
Martínez, M. M. M., Pestana, J. C. B., & Calderón, A. (2026) · Arquivo Brasileiro de Medicina Veterinária e Zootecnia · doi:10.1590/1678-4162-13803
Bariatric surgery and risk of dementia and Parkinson’s disease in patients with obesity
Shiekh, S. I., Papamargaritis, D., Goldney, J., Hernandes, G., Davies, M. J., Khunti, K., Yates, T. E., & Zaccardi, F. (2026) · International Journal of Obesity · doi:10.1038/s41366-026-02222-z
Self-citation
Metadata
- Authors
- Papamargaritis, D., & le Roux, C. W.
- Affiliations
- University of Leicester (GB)
- Diabetes Complications Research Centre, Conway Institute, University College of Dublin, Dublin 4, Ireland
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2021-02-26
- Volume
- 13
- Issue
- 3
- Pages
- 762
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC7996890
- OpenAlex
- W3134150619
- Cited by
- 68
- References
- 182
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 20 · 2023: 13 · 2022: 10 · 2021: 6
- FWCI
- 2.95
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Ulster University Research Portal (Ulster University) (acceptedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Lenus, The Irish Health Repository (Dr Steevens Hospital Library) (submittedVersion)
- Funders
- Health Research Board
- National Institute for Health and Care Research (CL-2017-11-001)
- Academy of Medical Sciences (SGL020\1002)
- Irish Research Council
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Keywords
- gastrointestinal hormones, bariatric surgery, Roux-en-Y gastric bypass, sleeve gastrectomy, obesity, weight loss, glucose homeostasis, type 2 diabetes remission, postprandial hypoglycemia, appetite regulation, satiety, hunger, octreotide, exendin-9-39, GLP-1 receptor
- MeSH terms
- Adult, Blood Glucose, Combined Modality Therapy, Eating, Female, Gastrectomy, Gastrointestinal Hormones, Humans, Hunger, Male, Middle Aged, Obesity, Morbid, Peptide Fragments, Postoperative Period, Satiation, Octreotide, Gastric Bypass, Biomarkers, Weight Loss, Treatment Outcome, Bariatric Surgery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
